Matthew K. Szot

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
7 years
Director since
2023

7 years of board service in total across 2 boards, counting each seat separately. Longest: INVO Fertility Inc., 3 years.

3 years · Since 2023
SenesTech Inc. Director
3 years · Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Dec 29, 2025 Cadrenal Therapeutics Inc. Open-market sale −9,933 $6.97 $69,233
Dec 4, 2025 INVO Fertility Inc. Other −3 — —
Dec 3, 2025 INVO Fertility Inc. Open-market sale −4 $1.52 $6
Nov 14, 2025 SenesTech Inc. Open-market sale −1 $2.75 $3
Oct 27, 2025 Cadrenal Therapeutics Inc. Open-market sale −1,800 $13.99 $25,182
Oct 24, 2025 Cadrenal Therapeutics Inc. Open-market sale −1,800 $13.99 $25,182
Oct 13, 2025 Cadrenal Therapeutics Inc. Open-market sale −1,800 $14.07 $25,326
Oct 9, 2025 Cadrenal Therapeutics Inc. Open-market sale −1,693 $13.99 $23,685
Oct 6, 2025 Cadrenal Therapeutics Inc. Open-market sale −107 $13.99 $1,497
Oct 1, 2025 Cadrenal Therapeutics Inc. Open-market sale −1,700 $13.99 $23,783
Sep 29, 2025 Cadrenal Therapeutics Inc. Open-market sale −100 $14.00 $1,400
Sep 25, 2025 Cadrenal Therapeutics Inc. Open-market sale −10,900 $14.05 $153,145
Sep 24, 2025 Cadrenal Therapeutics Inc. Open-market sale −1,500 $14.00 $21,000
Aug 28, 2025 Cadrenal Therapeutics Inc. Open-market sale −400 $14.00 $5,600
Aug 27, 2025 Cadrenal Therapeutics Inc. Open-market sale −1,600 $14.00 $22,400

Questions about Matthew K. Szot

What boards is Matthew K. Szot on?

Matthew K. Szot sits on the boards of INVO Fertility Inc. and SenesTech Inc.

How long has Matthew K. Szot served on boards?

Our records show at least 7 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.